Answers are grounded in this paper and cite their sources.
Purpose Nocardia spp. are a rare source of ocular infection, frequently complicated by delay in diagnosis, complicated treatment course, and increasing resistance to first-line therapies. Rose Bengal photodynamic antimicrobial therapy (RB-PDAT) has demonstrated broad-spectrum efficacy in vitro and in vivo pilot trials. However, while there is in vitro evidence of its efficacy in Nocardia isolates, its clinical use against Nocardia has not been previously described.Methods Retrospective multi-center case series.Results We present three cases of Nocardia ocular infection treated with adjunctive RB-PDAT: two cases of Nocardia niwae and one case of N. amikacinitolerans. All patients experienced failed empiric antimicrobial therapy prior to species-directed antibiotic treatment and RB-PDAT, with infection resolution at follow-up. One case of N. niwae was notable for direct scleral extension with recurrent subconjunctival abscess formation; abscess recurrence following RB-PDAT required salvage therapy with topical linezolid, which achieved definitive resolution.Conclusion These cases represent, to our knowledge, the first cases of Nocardia ocular infection treated with adjunctive RB-PDAT as well as the 2nd and 3rd case of N. niwae ocular infection. This data adds to existing literature suggesting the important role of adjunctive and rescue therapies in Nocardia infection, notably RB-PDAT and linezolid.
No takes yet. Share an insight, caveat, or question.
Adamek et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: